CoChat

GLP‐1 agonists for obesity and type 2 diabetes in children: Systematic review and meta‐analysis

Chadda, Karan R., Cheng, Tuck Seng, Ong, Ken K. · 2021 · Obesity Reviews
Cited by 103

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Summary: Pharmacological options for management of obesity and type 2 diabetes mellitus (T2DM) in children are limited. We aimed to synthesize published randomized controlled trial (RCT) evidence on the efficacy of glucagon‐like peptide‐1 (GLP‐1) agonists in T2DM, pre‐diabetes, and obesity in children aged <18 years. Inclusion criteria were RCTs of any GLP‐1 agonist, solely or in conjunction with other drugs, for the treatment of obesity, pre‐diabetes, and/or T2DM in children aged <18 years old. Nine studies met the inclusion criteria (two for T2DM, one for pre‐diabetes, and six for obesity without diabetes). In total, 286 children were allocated to GLP‐1 agonist therapy. Compared with controls, GLP‐1 agonist therapy reduced HbA1c by −0.30% (95% confidence interval [CI] −0.57, −0.04) with a larger effect in children with (pre‐)diabetes (−0.72%; 95% CI −1.17, −0.28; three studies) than in children with obesity (−0.08%; 95% CI −0.13, −0.02; four studies). Conversely, GLP‐1 agonist therapy reduced body weight more in children with obesity (−2.74 kg; 95% CI −3.77, −1.70; six studies) than in children with T2DM (−0.97 kg; 95% CI −2.01, 0.08; two studies). Adverse effects included gastrointestinal symptoms and minor hypoglycemic episodes, but not severe hypoglycemia. GLP‐1 agonists are efficacious in treating children with obesity and/or T2DM. Effect sizes are comparable with those reported in adults.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/obr.13177

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 19

  1. 10.1016/j.mayocp.2016.09.017 · DOI · Paper page
  2. 10.1111/ijpo.12495 · DOI · Paper page
  3. 10.1038/oby.2011.337 · DOI · Paper page
  4. 10.1089/dia.2013.0366 · DOI · Paper page
  5. 10.2337/dc18-0244 · DOI · Paper page
  6. 10.1016/S2352-4642(19)30236-6 · DOI
  7. 10.1056/NEJMoa1903822 · DOI · Paper page
  8. 10.1152/ajpendo.00639.2009 · DOI · Paper page
  9. 10.1016/j.ijcard.2016.06.028 · DOI
  10. 10.1016/j.jdiacomp.2016.08.018 · DOI
  11. 10.1007/s00592-017-1054-2 · DOI
  12. 10.3892/etm.2017.4129 · DOI
  13. 10.1016/j.jpeds.2016.10.076 · DOI · Paper page
  14. 10.1001/jamapediatrics.2013.1045 · DOI · Paper page
  15. Weghuber D, 2020, A 6‐month randomized, double‐blind, placebo‐controlled trial of weekly exenatide in adolescents with obesity, Pediatr Obes, e12624, 10.1111/ijpo.12624 · DOI · Paper page
  16. 10.5709/acp-0133-x · DOI · Paper page
  17. 10.18637/jss.v036.i03 · DOI · Paper page
  18. 10.1089/dia.2014.0188 · DOI · Paper page
  19. 10.1900/RDS.2014.11.202 · doi:10.1900/rds.2014.11.202

Cited by

See all 103

Metadata

Authors
Chadda, K. R., Cheng, T. S., & Ong, K. K.
Venue
Obesity Reviews
Publisher
Wiley
Published
2020-12-22
Volume
22
Issue
6
Pages
e13177-e13177
ISSN
  • 1467-7881 (ISSN-L)
  • 1467-789X
OpenAlex
W3113772690
Cited by
103
References
17
FWCI
2.25
Type
journal article
Language
en
Open access
closed
Funders
Medical Research Council Canada (MC_UU_12015/2)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.